These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3346559)

  • 41. Hermansky-Pudlak syndrome: infrequent bleeding and first report of Turkish and Pakistani kindreds.
    Harrison C; Khair K; Baxter B; Russell-Eggitt I; Hann I; Liesner R
    Arch Dis Child; 2002 Apr; 86(4):297-301. PubMed ID: 11919112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The Hermansky-Pudlak syndrome and the differential diagnosis of oculocutaneous albinism (author's transl)].
    Böhles H; Skrodzki K; Geissendörfer C; Krzywanek HJ
    Klin Padiatr; 1981 Jan; 193(1):3-6. PubMed ID: 6782329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes.
    Schallreuter KU; Pittelkow MR; Wood JM
    J Invest Dermatol; 1986 Dec; 87(6):728-32. PubMed ID: 2431070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated urinary dolichol excretion in the Hermansky-Pudlak syndrome. Indicator of lysosomal dysfunction.
    Witkop CJ; Wolfe LS; Cal SX; White JG; Townsend D; Keenan KM
    Am J Med; 1987 Mar; 82(3):463-70. PubMed ID: 3493691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NGS-based 100-gene panel of hypopigmentation identifies mutations in Chinese Hermansky-Pudlak syndrome patients.
    Wei A; Yuan Y; Bai D; Ma J; Hao Z; Zhang Y; Yu J; Zhou Z; Yang L; Yang X; Li L; Li W
    Pigment Cell Melanoma Res; 2016 Nov; 29(6):702-706. PubMed ID: 27593200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Partial Oculocutaneous Albinism: Two Siblings with Features of both Hermansky Pudlak and Waardenburg's Syndrome.
    Ishaq M; Niazi MK; Khan MS; Nadeem Y
    J Coll Physicians Surg Pak; 2015 Apr; 25 Suppl 1():S43-4. PubMed ID: 25933462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The management of gastrointestinal disease in Hermansky-Pudlak syndrome.
    Mora AJ; Wolfsohn DM
    J Clin Gastroenterol; 2011 Sep; 45(8):700-2. PubMed ID: 21085008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1.
    Brantly M; Avila NA; Shotelersuk V; Lucero C; Huizing M; Gahl WA
    Chest; 2000 Jan; 117(1):129-36. PubMed ID: 10631210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel mutation in a Turkish patient with Hermansky-Pudlak syndrome type 5.
    Korswagen LA; Huizing M; Simsek S; Janssen JJ; Zweegman S
    Eur J Haematol; 2008 Apr; 80(4):356-60. PubMed ID: 18182080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eye movement abnormalities in hermansky-pudlak syndrome.
    Gradstein L; FitzGibbon EJ; Tsilou ET; Rubin BI; Huizing M; Gahl WA
    J AAPOS; 2005 Aug; 9(4):369-78. PubMed ID: 16102489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hermansky-Pudlak syndrome: models for intracellular vesicle formation.
    Shotelersuk V; Gahl WA
    Mol Genet Metab; 1998 Oct; 65(2):85-96. PubMed ID: 9787100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5.
    Stephen J; Yokoyama T; Tolman NJ; O'Brien KJ; Nicoli ER; Brooks BP; Huryn L; Titus SA; Adams DR; Chen D; Gahl WA; Gochuico BR; Malicdan MC
    PLoS One; 2017; 12(3):e0173682. PubMed ID: 28296950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinico-molecular analysis of eleven patients with Hermansky-Pudlak type 5 syndrome, a mild form of HPS.
    Michaud V; Lasseaux E; Plaisant C; Verloes A; Perdomo-Trujillo Y; Hamel C; Elcioglu NH; Leroy B; Kaplan J; Jouk PS; Lacombe D; Fergelot P; Morice-Picard F; Arveiler B
    Pigment Cell Melanoma Res; 2017 Jan; 30(6):563-570. PubMed ID: 28640947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Linkage disequilibrium mapping of the gene for Hermansky-Pudlak syndrome to chromosome 10q23.1-q23.3.
    Fukai K; Oh J; Frenk E; Almodóvar C; Spritz RA
    Hum Mol Genet; 1995 Sep; 4(9):1665-9. PubMed ID: 8541858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low catalase levels in the epidermis of patients with vitiligo.
    Schallreuter KU; Wood JM; Berger J
    J Invest Dermatol; 1991 Dec; 97(6):1081-5. PubMed ID: 1748819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cross-sectional examination of visual acuity by specific type of albinism.
    Winsor CN; Holleschau AM; Connett JE; Summers CG
    J AAPOS; 2016 Oct; 20(5):419-424. PubMed ID: 27647118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations.
    DePinho RA; Kaplan KL
    Medicine (Baltimore); 1985 May; 64(3):192-202. PubMed ID: 3921802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells.
    Schallreuter KU; Wood JM
    Cancer Lett; 1987 Sep; 36(3):297-305. PubMed ID: 3652030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal translocation of tyrosinase and tyrosinase-related protein 1 in cutaneous melanocytes of Hermansky-Pudlak Syndrome and in melanoma cells transfected with anti-sense HPS1 cDNA.
    Sarangarajan R; Budev A; Zhao Y; Gahl WA; Boissy RE
    J Invest Dermatol; 2001 Sep; 117(3):641-6. PubMed ID: 11564171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validity of the 'bioassay' for thioredoxin-reductase activity.
    Fuchs J
    Arch Dermatol; 1988 Jun; 124(6):849-51. PubMed ID: 3377515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.